Incyte Financial Statements (INCY)
|
|
Report date
|
|
|
09.02.2021 |
08.02.2022 |
07.02.2023 |
31.12.2023 |
16.02.2024 |
|
29.10.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
2 667 |
2 986 |
3 395 |
3 696 |
3 696 |
|
4 076 |
Operating Income, bln rub |
|
|
-240.3 |
585.8 |
579.4 |
620.5 |
620.5 |
|
-52.0 |
EBITDA, bln rub |
? |
|
-178.2 |
630.2 |
599.6 |
904.7 |
919.4 |
|
220.4 |
Net profit, bln rub |
? |
|
-295.7 |
948.6 |
340.7 |
597.6 |
597.6 |
|
32.5 |
|
OCF, bln rub |
? |
|
-124.6 |
749.5 |
969.9 |
496.5 |
496.5 |
|
101.8 |
CAPEX, bln rub |
? |
|
187.4 |
181.0 |
77.8 |
47.5 |
47.5 |
|
85.0 |
FCF, bln rub |
? |
|
-312.0 |
568.5 |
892.1 |
449.0 |
449.0 |
|
16.8 |
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
OPEX, bln rub |
|
|
2 776 |
2 235 |
2 596 |
2 791 |
1 190 |
|
3 780 |
Cost of production, bln rub |
|
|
131.3 |
151.0 |
207.0 |
255.0 |
255.0 |
|
309.8 |
R&D, bln rub |
|
|
2 216 |
1 458 |
1 586 |
1 628 |
1 628 |
|
2 585 |
Interest expenses, bln rub |
|
|
2.17 |
1.91 |
2.67 |
2.55 |
2.55 |
|
2.67 |
|
Assets, bln rub |
|
|
3 561 |
4 933 |
5 841 |
6 782 |
6 782 |
|
5 012 |
Net Assets, bln rub |
? |
|
2 611 |
3 770 |
4 370 |
5 190 |
5 190 |
|
3 171 |
Debt, bln rub |
|
|
34.9 |
34.3 |
44.6 |
38.3 |
38.3 |
|
36.5 |
Cash, bln rub |
|
|
1 801 |
2 348 |
3 239 |
3 656 |
3 656 |
|
1 775 |
Net debt, bln rub |
|
|
-1 767 |
-2 314 |
-3 194 |
-3 618 |
-3 618 |
|
-1 738 |
|
Ordinary share price, rub |
|
|
87.0 |
73.4 |
80.3 |
62.8 |
62.8 |
|
54.0 |
Number of ordinary shares, mln |
|
|
218.1 |
220.4 |
222.0 |
225.9 |
223.6 |
|
192.6 |
|
Market cap, bln rub |
|
|
18 968 |
16 179 |
17 831 |
14 186 |
14 042 |
|
10 396 |
EV, bln rub |
? |
|
17 201 |
13 865 |
14 637 |
10 568 |
10 424 |
|
8 658 |
Book value, bln rub |
|
|
2 283 |
3 464 |
4 085 |
4 911 |
4 911 |
|
2 896 |
|
EPS, rub |
? |
|
-1.36 |
4.30 |
1.53 |
2.65 |
2.67 |
|
0.17 |
FCF/share, rub |
|
|
-1.43 |
2.58 |
4.02 |
1.99 |
2.01 |
|
0.09 |
BV/share, rub |
|
|
10.5 |
15.7 |
18.4 |
21.7 |
22.0 |
|
15.0 |
|
EBITDA margin, % |
? |
|
-6.68% |
21.1% |
17.7% |
24.5% |
24.9% |
|
5.41% |
Net margin, % |
? |
|
-11.1% |
31.8% |
10.0% |
16.2% |
16.2% |
|
0.80% |
FCF yield, % |
? |
|
-1.64% |
3.51% |
5.00% |
3.17% |
3.20% |
|
0.16% |
ROE, % |
? |
|
-11.3% |
25.2% |
7.80% |
11.5% |
11.5% |
|
1.02% |
ROA, % |
? |
|
-8.30% |
19.2% |
5.83% |
8.81% |
8.81% |
|
0.65% |
|
P/E |
? |
|
-64.1 |
17.1 |
52.3 |
23.7 |
23.5 |
|
320.1 |
P/FCF |
|
|
-60.8 |
28.5 |
20.0 |
31.6 |
31.3 |
|
618.7 |
P/S |
? |
|
7.11 |
5.42 |
5.25 |
3.84 |
3.80 |
|
2.55 |
P/BV |
? |
|
8.31 |
4.67 |
4.36 |
2.89 |
2.86 |
|
3.59 |
EV/EBITDA |
? |
|
-96.5 |
22.0 |
24.4 |
11.7 |
11.3 |
|
39.3 |
Debt/EBITDA |
|
|
9.91 |
-3.67 |
-5.33 |
-4.00 |
-3.93 |
|
-7.89 |
|
R&D/CAPEX, % |
|
|
1 183% |
805.6% |
2 038% |
3 428% |
3 428% |
|
3 040% |
|
CAPEX/Revenue, % |
|
|
7.03% |
6.06% |
2.29% |
1.28% |
1.28% |
|
2.09% |
|
Incyte shareholders |